Transporter molecules influence the gene expression in HeLa cells.

Area of Science:

• Pharmacology
• Molecular Biology
• Cell Biology

Background:

• Bioactive substances often have poor bioavailability due to physicochemical properties, limiting their therapeutic efficacy.
• Transport carrier molecules are designed to enhance cellular entry and delivery of bioactive cargo to molecular targets.
• While cargo molecule effects are studied, the impact of carrier molecules on target cells requires further investigation.

Purpose of the Study:

• To investigate the effects of transmembrane transport peptides, specifically pAnt and HIV-1 Tat, on gene expression in target cells.
• To identify specific genes affected by these carrier molecules and analyze the nature of their differential expression.
• To understand the implications of carrier-induced gene expression changes for interpreting pharmacological data.

Main Methods:

• Application of pAnt and HIV-1 Tat transmembrane transport peptides to cells.
• Analysis of differential gene expression using methods to identify induced and repressed genes.
• Description of affected genes, chromosomes, and graphical representation of gene expression changes.

Main Results:

• Transmembrane transport peptides, pAnt and HIV-1 Tat, induced significant alterations in cellular gene expression.
• Specifically, the PKN1 gene was induced, while the ZCD1 and BSG genes were moderately repressed.
• Differential gene expression patterns were mapped to specific genes and chromosomes, with moderate changes visualized graphically.

Conclusions:

• Carrier molecules, such as pAnt and HIV-1 Tat, can elicit distinct gene expression responses in cells.
• Understanding these carrier-mediated effects is crucial for accurate interpretation of data from highly specific active pharmaceutical products.
• Further research into carrier molecule interactions with cellular systems is necessary to optimize drug delivery and therapeutic outcomes.